Market revenue in 2023 | USD 626.9 million |
Market revenue in 2030 | USD 1,013.9 million |
Growth rate | 7.1% (CAGR from 2023 to 2030) |
Largest segment | Dogs |
Fastest growing segment | Cats |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dogs, Cats |
Key market players worldwide | Merck & Co Inc, Zoetis, BD, Boehringer Ingelheim, ACON Laboratories, Taidoc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pet diabetes care market will help companies and investors design strategic landscapes.
Dogs was the largest segment with a revenue share of 51.94% in 2023. Horizon Databook has segmented the U.S. pet diabetes care market based on dogs, cats covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held the largest share of the North American pet diabetes care market in 2022 due to the rising pet population rate with higher risks of chronic illnesses such as diabetes. The increase in concerns of owners regarding their pets’ healthcare has boosted pet care expenditure in the country, driving the market.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. pet diabetes care market , including forecasts for subscribers. This country databook contains high-level insights into U.S. pet diabetes care market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account